MESA investigators found a significant interaction between hs-CRP and Lp(a)-associated ASCVD risk, in which elevated Lp(a) levels were associated with primary ASCVD risk only in individuals with concomitant elevated hs-CRP levels (>2 mg/L) [12]. This evidence concerns the gene MAP3K14 and atherosclerosis.